715-14-0

Usage

Uses

Used in Pharmaceutical Synthesis:
(2E)-3-[(4-chlorophenyl)sulfonyl]prop-2-enoic acid is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
(2E)-3-[(4-chlorophenyl)sulfonyl]prop-2-enoic acid is also utilized in the production of agrochemicals, contributing to the creation of effective products for agricultural use, such as pesticides and herbicides.
Used in Organic Chemistry Research:
(2E)-3-[(4-chlorophenyl)sulfonyl]prop-2-enoic acid serves as a valuable building block in organic chemistry, enabling researchers to explore novel reactions and syntheses that could lead to the discovery of new chemical compounds.
Used in Material Science:
Its potential applications in material science include the development of new materials with specific properties, such as improved stability or reactivity, which can be beneficial in various industrial applications.

Upstream product

• 880-32-0 3-(4-chlorophenylthio)-2(E)-propenoic acid 

Relevant academic research and scientific papers

Styrene sulfone NLRP3 inflammasome inhibitor, preparation method and application thereof

The invention relates to the field of styrene sulfone compounds and NLRP3 inhibitors, and particularly provides a styrene sulfone NLRP3 inflammasome inhibitor, a preparation method and application thereof, wherein the inhibitor is represented by a formula (1), n is selected from 0 and 1, X is selected from N and O, R1 is selected from different electron withdrawing or electron donating substituents, and R2 is selected from different fat or aromatic substituents. According to the invention, it is verified that the compounds represented by the general formula have NLRP3 inhibitory activity.

Pharmaceutical compositions containing acrylic acid derivatives and their use in the medicine

Known acrylic acid derivatives of formula wherein, n is an integer of from 0 to 2,R represents a hydrogen, an alkaline or an alkaline earth metal atom, or a C1 4alkyl-group, and, R1 represents a hydrogen or a halogen atom or a C

Novel acrylic acid salts, a process for their preparation, pharmaceutical compositions containing them and their use in the medicine

Novel acrylic acid salts of formula STR1 wherein R represents a hydrogen or a halogen atom, a C1-4 alkyl, a C1-4 alkoxy or a nitro group, M represents a cation derived from bismuth, zinc or a pharmaceutically acceptable organic base,

Novel acrylic acid salts, a process for their preparation, pharmaceutical compositions containing them and their use in the medicine

Novel acrilic acid salts of formula wherein, R represents a hydrogen or a halogen atom, a C1 4alkyl,a C1 4alkoxy or a nitro group,M represents a cation derived from bismuth, zinc or a pharmaceutically acceptable